Tenshi Pharmaceuticals Private Limited has pledged 2,000,000 equity shares of Onesource Specialty Pharma Limited on December 16, 2025, representing 1.75% of the total share capital. This pledge is due to certain business/operational needs. Post this event, the total encumbered shares stand at 9,437,176, representing 8.24% of the total share capital.
Pledge of Shares
Tenshi Pharmaceuticals Private Limited has announced a pledge of 2,000,000 equity shares of Onesource Specialty Pharma Limited. The transaction occurred on December 16, 2025.
Details of Encumbrance
The pledge represents 1.75% of the total share capital of Onesource Specialty Pharma Limited. The reason for the encumbrance is attributed to certain business and operational needs. The shares have been pledged in favor of Catalyst Trusteeship Limited.
Post-Event Holding
Following this event, the total number of encumbered shares of Onesource Specialty Pharma Limited stands at 9,437,176, which is equivalent to 8.24% of the total share capital. The promoter, Tenshi Pharmaceutical Private Limited’s encumbered holding after the current event is 8,651,274 shares, or 7.55% of total capital.
Promoter Holdings
As of December 18, 2025, Tenshi Pharmaceuticals Private Limited holds 20,524,714 shares, representing 17.91% of the total share capital. Prior to this event, their holding of encumbered shares was 6,651,274 representing 5.80% of the total share capital.
Source: BSE
